Company Description
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States.
It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities.
The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems.
It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants.
The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
| Country | United States |
| Founded | 1997 |
| IPO Date | Sep 21, 2004 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 31 |
| CEO | Robert Banks |
Contact Details
Address: 380 Lackawanna Place South Orange, New Jersey 07079 United States | |
| Phone | 201 343 5202 |
| Website | nephros.com |
Stock Details
| Ticker Symbol | NEPH |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001196298 |
| CUSIP Number | 640671400 |
| ISIN Number | US6406714005 |
| Employer ID | 13-3971809 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Robert Banks | President, Chief Executive Officer and Director |
| Judy F. Krandel C.F.A. | Chief Financial Officer |
| Brianne McGuire | Director of Brand, Marketing and Business Development |
| Vashone R. Thomas | Vice President of Quality, Regulatory, and Human Resources |
| Greg Lucas | President of Aether Water Systems |
| Judy Mazzini | Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 12, 2026 | 10-K | Annual Report |
| Nov 26, 2025 | 8-K | Current Report |
| Nov 14, 2025 | SCHEDULE 13G | Filing |
| Nov 6, 2025 | 10-Q | Quarterly Report |
| Aug 11, 2025 | 8-K | Current Report |
| Aug 7, 2025 | 10-Q | Quarterly Report |
| Jun 16, 2025 | 8-K | Current Report |
| May 15, 2025 | 10-Q | Quarterly Report |
| May 8, 2025 | 8-K | Current Report |
| Apr 30, 2025 | ARS | Filing |